Principles and guidelines for surgeons - Management of symptomatic breast cancer

European Journal of Surgical Oncology

Volumn 23, Issue 2, 1997, Pages 101-109

  Blichert Toft, M ^a   Smola, M G ^b   Cataliotti, L ^c   O'Higgins, N ^d  

^a Rigshospitalet   (Denmark)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER SURGERY; FEMALE; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGEON;

EID: 0031005969     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)80001-7     Document Type: Review

References (45)

1. van Dongen JA. Present and future state of surgical management in breast cancer. Eur J Surg 1996; 162: 87-91.
2. Baum M. Breast cancer 2000 BC to 2000AD - Time for a paradigm shift? Acta Oncol 1993; 32: 3-8.
3. Eindhoven Cancer Registry. Breast cancer. In: Coeberg JWW, Heijden LH van der, Janssen-Heijnen MLG, (eds) Cancer Incidence and Survival in the Southeast of the Netherlands. Eindhoven; IKZ, 1995: 54-6.
4. Ewertz M. Breast Cancer in Denmark. Incidence, Risk Factors, and Characteristics of Survival. Copenhagen: DataGraf Auning AS, 1993: 7-27.
5. Association of the Nordic Cancer Registries. Cancer of the breast. Females. In: Engeland A, Haldorsen T, Tretli S, et al. (eds) Prediction of Cancer Mortality in the Nordic Countries up to the Years 2000 and 2010, on the Basis of Relative Survival Analysis APMIS 1995: 103 (Suppl. 49): 72-4.
6. Micheli A, Verdecchia A, Capocaccia R, et al. Estimated incidence and prevalence of female breast cancer in Italian regions. Tumori 1992; 78: 13-21.
7. Andreasen AH, Mouridsen HT, Andersen KW, Lynge E, Madsen M, Olesen KP. Equity and improvement in outcome of breast cancer in Denmark. In: France FHR, Goor JN van, Johansen KS, (eds) Case-based Telematic Systems towards Equity in Health Care. Amsterdam, IOS Press, 1994: 27-38.
8. Eberlein TJ. Preoperative chemotherapy: where do we go from here. Ann Surg 1995; 222: 609-11.
9. Saran P, Bord MA. Multi-disciplinary breast cancer center: experience at the University of Michigan. In: Harness JK, Oberman HA, Lichter AS, Adler DD, Cody RL, (eds) Breast Cancer. Collaborative Management. Michigan: Lewis Publishers, 1988: 265-72.
10. The Breast Surgeons Group of the British Association of Surgical Oncology. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom. Eur J Surg Oncol 1995; 21 (Suppl. A): 1-13.
11. Paci E, Zappa M, Palli D, Girogi D, Cariddi A, et al. Changes in stage and treatment of breast cancer in Florence from 1985-1990. The Breast 1994; 3: 109-112.
12. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. Br Med J 1996; 312: 145-8.
13. Blichert-Toft M, Mouridsen HT, Andersen KW. Clinical trials. Sem Surg Oncol 1996; 12: 32-38.
14. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984; 3: 409-22.
15. The Danish National Health Board. Brystkraeft - Tidlig opsporing og undersøgelse. Report ISBN: 87-89638-39-5. Copenhagen, 1994: 1-144.
16. Blichert-Toft M, Dyreborg U, Andersen J. Diagnostic strategy in the management of patients with breast symptoms. A recommended design and present experience. Acta Oncol 1988;27: 597-600.
17. Danish Breast Cancer Co-Operative Group. DBCG Protocol Collection 1989. Copenhagen: Rigshospitalet, 1989; 3: 1-179.
18. van Dongen JA. Early breast cancer. Acta Oncol 1989; 28: 123-34.
19. Balch CM, Singletary SE, Bland KI. Clinical decision-making in early breast cancer. Ann Surg 1993; 217: 207-25.
20. Tubiana M, Holland R, Kopans DB, et al. Management of non-palpable and small lesions found in mass breast screening. Eur J Cancer 1994; 30A: 538-47.
21. Ciatto S, Rosselli Del Turco M, et al. Non palpable lesions of the breast detected by mammography. Review of 1182 consecutive histologically confirmed cases. Eur J Cancer 1994; 30A: 40-4.
22. Azavedo E, Cataliotti L, Ciatto S, Perry N, Svane G, Vielh P. European Society of Mastology Study Group on detection and diagnosis. Proceedings of the EUSOMA seminar on non palpable breast lesions 18th June 1993. Recommendations for the management of non palpable lesions detected by mammography. The Breast 1994; 3: 241-5.
23. Olsson H, Borg Å. Genetic predisposition to breast cancer. Acta Oncol 1996; 35: 1-8.
24. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 1995; 31A: 1574-9.
25. Sacks NPM, Barr LC, Allan SM, Baum M. The role of axillary dissection in operable breast cancer. The Breast 1992; 1: 41-9.
26. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 1988; 14: 407-12.
27. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992; 28A: 1415-8.
28. Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol 1992; 31: 29-35.
29. Reynolds JV, Mercer P, McDcrmott EWM, Cross S, Stokes M, Murphy D, O'Higgins NJ. Audit of complete axillary dissection in early breast cancer. Eur J Cancer 1994: 30A: 148-9.
30. Recht A, Dongen JA van, Fentiman IS, Holland R, Peterse JL. Third meeting of the DCIS working party of the EORTC. Conference report. Eur J Cancer 1994; 30A: 1895-901.
31. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Stekhoven JHS. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519-22.
32. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1992: 16: 1183-96.
33. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Lobular carcinoma in situ of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1993; 17: 14-21.
34. Silverstein MJ. Non-invasive breast cancer. The dilemma of the 1990's. Obstet Gynec Clin North Am 1994; 21: 639-58.
35. Galea MH, Blarney RW, Elston CE, Ellis IO. The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-19.
36. Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT. The Nottingham prognostic index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 1994; 32 :281-90.
37. Rosselli del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. JAMA 1994; 271: 1593-7.
38. The GIVIO investigators. Impact of follow-up testing on survival and health-related quality of life in. breast cancer patients. A multicentre randomized controlled trial. JAMA 1994; 271: 1587-92.
39. Salvadori B. Local recurrences after breast-conserving treatment: an open problem. Sem Surg Oncol 1996; 12: 46-52.
40. International Union Against Cancer, UICC. Breast tumours (ICD-o 174). In: Hermanek P, Sobin LH, (eds) TNM Classification of Malignant Tumours (4th edn). Berlin, Springer-Verlag, 1987: 93-9.
41. Rutgers EJTh, Peterse HL. Future prospects for the staging of breast cancer. Sem Surg Oncol 1996; 12: 3-11.
42. EORTC Breast Cancer Cooperative Group. Manual for Clinical Research in Breast Cancer. Leuven. 1991: 1-106.
43. Tagnon HJ. Ethical considerations in controlled clinical trials. In: Buyse ME, Staquet MJ, Sylvester RJ, (eds) Cancer Clinical Trials. Methods and Practice. Oxford: Oxford University Press, 1984: 14-25.
44. Buyse M. Randomized clinical trails in surgical oncology. Eur J Surg Oncol 1991; 17: 421-8.
45. Zelen M. Randomized consent designs for clinical trials: an update. Stat Med 1990; 9: 645-56.